Anesthesiology
1 questionsWhich anaesthetic agent has maximum MAC ?
NEET-PG 2013 - Anesthesiology NEET-PG Practice Questions and MCQs
Question 471: Which anaesthetic agent has maximum MAC ?
- A. Ether
- B. Methoxyfluorane
- C. Halothane
- D. Nitrous Oxide (N2O) (Correct Answer)
Explanation: ***Nitrous Oxide (N2O)*** - **Nitrous Oxide** has the highest **minimum alveolar concentration (MAC)** of all commonly used inhalational anesthetics, approximately 104%. - A high MAC indicates **low potency**, meaning that a large concentration is required to achieve anesthetic effects. *Ether* - **Ether** has a MAC of about 1.92%, which is significantly lower than that of Nitrous Oxide. - Its use has largely been replaced due to its flammability, slow induction, and recovery times. *Methoxyfluorane* - **Methoxyfluorane** is known for having a very low MAC, around 0.16%, making it the most potent inhalational anesthetic. - Due to its high potency and significant nephrotoxicity, its use is now very limited. *Halothane* - **Halothane** has a MAC of approximately 0.75%. - While it was a widely used inhalational anesthetic, it has largely been replaced due to concerns about **halothane hepatitis** and arrhythmogenicity.
Community Medicine
1 questionsA person has lost his leg in an accident and is unable to walk. This condition is classified as -
NEET-PG 2013 - Community Medicine NEET-PG Practice Questions and MCQs
Question 471: A person has lost his leg in an accident and is unable to walk. This condition is classified as -
- A. Disability (Correct Answer)
- B. Medical condition
- C. Physical limitation
- D. Mobility challenge
Explanation: ***Disability*** - The loss of a limb leading to inability to walk is classified as a **disability** because it significantly impairs a major life activity. - According to the **WHO International Classification of Functioning, Disability and Health (ICF)**, disability is an **umbrella term** encompassing impairments (loss of limb), activity limitations (inability to walk), and participation restrictions. - The scenario describes both an **impairment** (anatomical loss) and an **activity limitation** (functional consequence), which together constitute a **disability**. *Medical condition* - While the accident caused a medical condition (trauma, amputation), the term "medical condition" describes the **disease or injury state** itself, not its functional impact. - The question asks for the **classification** of the inability to walk, which is a functional consequence, not the primary medical diagnosis. *Physical limitation* - This is a **descriptive term** for restricted physical capacity but not a standard **classification** in public health terminology. - In the WHO ICF framework, this would fall under "activity limitation," which is a component of disability rather than a separate classification. *Mobility challenge* - This is a colloquial or lay term describing the **difficulty in moving** but lacks the specificity of formal medical classification. - While accurate descriptively, it does not represent the **standardized terminology** used in Community Medicine and rehabilitation frameworks.
Internal Medicine
1 questionsSite for injection of cell culture rabies vaccine-
NEET-PG 2013 - Internal Medicine NEET-PG Practice Questions and MCQs
Question 471: Site for injection of cell culture rabies vaccine-
- A. Gluteus
- B. Subcutaneous
- C. Deltoid (Correct Answer)
- D. Anterior abdominal wall
Explanation: Deltoid - The **deltoid muscle** is the recommended site for intramuscular injection of cell culture rabies vaccine due to its size and accessibility [1]. - Intramuscular administration in this area ensures optimal vaccine absorption and immunogenicity [1]. Gluteus - The **gluteus muscle** is not the preferred site for rabies vaccine due to the risk of injecting into fat, which can lead to reduced immune response [1]. - Additionally, there is a higher risk of **sciatic nerve injury** with gluteal injections. Subcutaneous - **Subcutaneous administration** is not the standard route for cell culture rabies vaccines as it can lead to slower absorption and potentially a less robust immune response. - This route is typically reserved for specific vaccine types or in situations where intramuscular injection is contraindicated. Anterior abdominal wall - The **anterior abdominal wall** is an unsuitable site for intramuscular injection of rabies vaccine. - This area is primarily used for **subcutaneous injections** (e.g., insulin) and lacks sufficient muscle mass for effective intramuscular vaccine delivery.
Microbiology
6 questionsWhich of the following bacteria is known to exhibit antigenic variation?
Which of the following statements about interleukin-1 is false?
All are true regarding the development of T-cells, except?
Which of the following is a superantigen ?
What is the primary use of the Hybridoma technique?
Prions are best killed by
NEET-PG 2013 - Microbiology NEET-PG Practice Questions and MCQs
Question 471: Which of the following bacteria is known to exhibit antigenic variation?
- A. Yersinia
- B. Bordetella
- C. Brucella
- D. Borrelia (Correct Answer)
Explanation: ***Borrelia*** - *Borrelia* species, particularly *Borrelia burgdorferi* (causing **Lyme disease**), are known for extensive **antigenic variation** of their outer surface proteins (Osps), especially OspC. - This variation helps the bacteria evade the host's immune response, contributing to persistent infection. *Yersinia* - While *Yersinia* species produce various virulence factors, including proteins that interfere with immune cell function, they are not primarily known for the type of rapid and extensive **antigenic variation**seen in *Borrelia*. - Their immune evasion strategies often involve modifying host cell signaling pathways and resisting phagocytosis. *Bordetella* - *Bordetella pertussis*, causative agent of **whooping cough**, varies its expression of adhesins and toxins through **phase variation**, which is a form of phenotypic switching. - However, this is distinct from the frequent and sequential changes in surface antigens (antigenic variation) observed in *Borrelia*. *Brucella* - *Brucella* species are **intracellular pathogens** that primarily evade the immune system by surviving and replicating within host cells. - They do not typically engage in significant **antigenic variation** of their surface components as a primary immune evasion mechanism.
Question 472: Which of the following statements about interleukin-1 is false?
- A. IL-1 is an endogenous pyrogen.
- B. The primary source of IL-1 is the monocyte-macrophage system.
- C. IL-1 inhibits IL-2 production by T-cells. (Correct Answer)
- D. IL-1 promotes acute phase protein synthesis in the liver.
Explanation: ***IL-1 inhibits IL-2 production by T-cells*** - This statement is false because **IL-1** actually **enhances the production of IL-2** by T-cells, which is crucial for T-cell proliferation and immune response. - **IL-1 acts synergistically with IL-6 and TNF-α** to promote inflammation and immune cell activation, where IL-2 plays a key role. *The primary source of IL-1 is the monocyte-macrophage system* - This statement is true; **monocytes and macrophages** are the main producers of **IL-1α and IL-1β** upon activation by various stimuli. - Other cells, such as neutrophils, dendritic cells, and endothelial cells, can also produce IL-1, but monocytes and macrophages are the predominant source. *IL-1 is an endogenous pyrogen* - This statement is true; **IL-1** is a potent **endogenous pyrogen** that acts on the hypothalamus to induce fever, a hallmark of the acute phase response. - It triggers prostaglandin synthesis in the hypothalamus, leading to an elevation in the body's thermoregulatory set point. *IL-1 promotes acute phase protein synthesis in the liver* - This statement is true; **IL-1** is a key mediator that stimulates **hepatocytes** to produce **acute phase proteins**, such as C-reactive protein and serum amyloid A. - This hepatic response is part of the innate immune system's effort to control infection and inflammation.
Question 473: All are true regarding the development of T-cells, except?
- A. T-cells are formed in bone marrow
- B. In lymph nodes, T-cells are found in paracortical area
- C. Maturation of T-cells take place in thymus
- D. T-cells are located in mantle layer of spleen (Correct Answer)
Explanation: ***T-cells are located in mantle layer of spleen*** - The **mantle layer** (or marginal zone) of the spleen is primarily associated with **B-lymphocytes**, which are involved in antibody production. - While T-cells are present in the spleen, they are predominantly found in the **periarteriolar lymphoid sheath (PALS)**, which is part of the white pulp, rather than the mantle layer. *T-cells are formed in bone marrow* - **Hematopoietic stem cells** in the **bone marrow** are the progenitors of all blood cells, including lymphocytes. - These stem cells differentiate into **lymphoid stem cells**, which then travel to the thymus to become T-cells. *Maturation of T-cells take place in thymus* - **T-cell precursors** migrate from the bone marrow to the **thymus**, where they undergo a complex process of differentiation and selection. - In the thymus, T-cells acquire their **T-cell receptors (TCRs)** and undergo positive and negative selection to ensure they are self-MHC restricted and tolerant to self-antigens. *In lymph nodes, T-cells are found in paracortical area* - The **paracortical area** (or paracortex) of the lymph node is the **T-cell zone**, rich in T-lymphocytes and dendritic cells. - This region is crucial for the interaction between T-cells and antigen-presenting cells, initiating adaptive immune responses.
Question 474: Which of the following is a superantigen ?
- A. Cholera toxin
- B. Diphtheria toxin
- C. TSST (Correct Answer)
- D. Vero-cytoxin
Explanation: ***TSST*** - **Toxic Shock Syndrome Toxin-1 (TSST-1)** is a classic example of a superantigen produced by *Staphylococcus aureus*. - Superantigens **bind directly to MHC class II molecules and T-cell receptors (TCRs)** outside of the antigen-binding groove, leading to non-specific activation of a large percentage of T cells and a massive release of cytokines. *Cholera toxin* - **Cholera toxin** is an exotoxin produced by *Vibrio cholerae* that causes massive fluid secretion in the intestine by **activating adenylate cyclase** in enterocytes. - It functions by **ADP-ribosylating the Gs alpha subunit**, leading to constitutive activation of cyclic AMP production, but it is not a superantigen. *Diphtheria toxin* - **Diphtheria toxin**, produced by *Corynebacterium diphtheriae*, inhibits protein synthesis in eukaryotic cells by **ADP-ribosylating elongation factor-2 (EF-2)**. - This action leads to cell death and the characteristic pseudomembrane formation in diphtheria, but it does not act as a superantigen. *Vero-cytoxin* - **Vero-cytoxin** (also known as Shiga toxin or Shiga-like toxin) is produced by *E. coli* O157:H7 and other Shiga toxin-producing *E. coli* (STEC). - It inhibits protein synthesis by **cleaving ribosomal RNA**, primarily causing damage to intestinal cells and renal endothelial cells, but it is not a superantigen.
Question 475: What is the primary use of the Hybridoma technique?
- A. Monoclonal antibodies (Correct Answer)
- B. Antigen
- C. Specific antibodies
- D. Cytokines
Explanation: ***Monoclonal antibodies*** - The **hybridoma technique** is primarily used to produce **monoclonal antibodies (MAbs)**, which are highly specific antibodies derived from a single B-cell clone. - These antibodies recognize a **single epitope** on an antigen, providing exceptional specificity and uniformity. - The technique involves **fusing a B-lymphocyte** (antibody-producing cell) with a **myeloma cell** (immortal cancer cell) to create a hybridoma that continuously produces identical antibodies. - This is the **gold standard** for producing large quantities of identical, highly specific antibodies for diagnostic and therapeutic use. *Specific antibodies* - While monoclonal antibodies are indeed specific, this term is **too vague** and could refer to any antibody with specificity, including polyclonal antibodies. - **Polyclonal antibodies** are also specific but are produced through conventional immunization, not the hybridoma technique. - The defining characteristic of the hybridoma technique is that it produces **monoclonal** (single clone) antibodies, not just "specific" ones. *Antigen* - An **antigen** is a molecule that elicits an immune response and is used to immunize animals during antibody production. - However, antigens are the **input** for antibody production, not the **product** of the hybridoma technique. *Cytokines* - **Cytokines** are signaling molecules involved in immune cell communication and regulation. - They are not produced by the hybridoma technique, which is specifically designed for **antibody production**.
Question 476: Prions are best killed by
- A. Incineration at high temperatures
- B. Autoclaving at 134°C (for 18 minutes) (Correct Answer)
- C. 5% formalin solution
- D. Sodium hypochlorite solution
Explanation: ***Autoclaving at 134°C (for 18 minutes)*** - **Prions** are highly resistant to conventional sterilization methods, and **autoclaving at 134°C for at least 18 minutes** is the **most effective method for sterilizing reusable medical instruments** contaminated with prions. - This high temperature and pressure protocol (WHO/CDC recommended) helps to denature the misfolded protein structure of prions, reducing their infectivity to safe levels. - **In the context of sterilization and disinfection**, this is the best practical method for surgical instruments that cannot be discarded. *Incineration at high temperatures* - **Incineration at 800-1000°C** achieves complete combustion and is **highly effective** at destroying prions. - However, incineration is used only for **single-use disposable items** and prion-contaminated waste, not for reusable surgical instruments. - In the clinical context of sterilization (implied by this topic), autoclaving is the preferred answer as it applies to reusable equipment. *Sodium hypochlorite solution* - **Sodium hypochlorite** (bleach) at **high concentrations** (20,000 ppm or 2% available chlorine) for extended contact times (1+ hours) can inactivate prions. - However, it is **corrosive to instruments**, damages tissue samples, and requires precise concentration and exposure conditions, making it less practical than autoclaving. *5% formalin solution* - Formalin is **not effective at inactivating prions**; it can actually **preserve and stabilize** prion infectivity. - Formalin cross-links proteins and preserves tissue morphology but does not reliably break down the highly stable **beta-sheet structures** characteristic of prions.
Pathology
1 questionsABO isoantibodies are of which class?
NEET-PG 2013 - Pathology NEET-PG Practice Questions and MCQs
Question 471: ABO isoantibodies are of which class?
- A. IgG
- B. IgM (Correct Answer)
- C. IgD
- D. IgA
Explanation: ***IgM*** - Naturally occurring **ABO isoantibodies** are predominantly of the **IgM class**. - These **pentameric antibodies** are highly effective at causing **agglutination** of incompatible red blood cells, which is crucial in transfusion reactions [1]. *IgG* - While IgG antibodies can be formed against ABO antigens (e.g., in hemolytic disease of the newborn), the **naturally occurring isoantibodies** are primarily IgM. - IgG antibodies are **monomeric** and can cross the **placenta**, which is a key difference from the primary IgM ABO antibodies. *IgD* - **IgD** antibodies are primarily found on the surface of **B cells** and play a role in B cell activation. - They are **not a primary mediator** of ABO isoantibody response or red blood cell agglutination. *IgA* - **IgA** antibodies are predominantly found in **mucosal secretions** and play a role in mucosal immunity. - While some IgA may be present, it is **not the predominant class** for naturally occurring ABO isoantibodies involved in transfusion reactions. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 154-155.